It has also been demonstrated that β-arrestin is essential for the NK-1R-mediated proliferation of cancer cells and for the G2/M phase transition and that a deficiency in β-arrestin augmented the sensitivity of tumor cells to NK-1R antagonists [42]. The gene discussed is TACR1; the disease is cancer.